Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients, expected in 2Q 2025In parallel, the ...
CRISPR Therapeutics: An Uninspiring Start For Casgevy
CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...
Medscape3h
Is MS Subtyping Clinically Meaningful? Experts Weigh In
Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.
Verywell Health on MSN23h
8 Things to Know Before Taking Creatine Monohydrate
Creatine monohydrate is a popular supplement primarily taken to enhance muscle strength and power. However, it may provide other health benefits. Learn more about creatine monohydrate and what to ...